News & CommentXenotransplants

IOM Backs Cautious Experimentation

Science  19 Jul 1996:
Vol. 273, Issue 5273, pp. 305-306
DOI: 10.1126/science.273.5273.305b


A panel put together by the Institute of Medicine (IOM) concludes in a report released this week that the benefits of xenotransplants outweigh the risks that the procedure might permit animal pathogens to cross the species barrier into humans. The panel advises, however, that new trials should be delayed until the government has put some guidelines into place. The U.S. Department of Health and Human Services is now finalizing rules that mirror those suggested by the IOM panel, and experiments, which have been on hold for several months, may soon be resumed.